Bristol Myers Squibb Co: director Theodore R. Samuels II received 821.314 shares

What happened

• Theodore R. Samuels II, a director of Bristol Myers Squibb Co, received 821.314 deferred share units (reported as a derivative acquisition) at $62.40 per unit on Sep 30, 2026, for a reported value of $51,250.

Key details

• Transaction date and price: Sep 30, 2026 at $62.40 per unit.
• Shares owned after the transaction: not stated in the filing.
• Footnotes:
  • Each deferred share unit will be converted into a share of common stock upon settlement. The deferred share units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
  • Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
• Filing timeliness: not indicated as late in the provided information.

Why it may matter

• This filing reports a grant of deferred share units that are a derivative award and will convert to shares upon settlement rather than an open-market purchase or sale.
• The filing does not show why the insider traded or why the company acted.